>
Myomo Inc logo

MYO - Myomo Inc Share Price

$10.38 0.0  0.0%

Last Trade - 15/04/21

Sector
Healthcare
Size
Micro Cap
Market Cap £42.0m
Enterprise Value £33.2m
Revenue £5.50m
Position in Universe 5533rd / 6851
Bullish
Bearish
Unlock MYO Revenue
Momentum
Relative Strength (%)
1m -30.7%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -45.0%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.69 1.10 1.56 2.44 3.84 7.58 11.7 17.0 +61.5%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, MyomoInc revenues increased 98% to $7.6M. Net loss applicable tocommon stockholders increased 6% to $12.2M. Revenuesreflect an increase in demand for the Company's productsand services due to favorable market conditions. Higher netloss reflects Selling, general and administrative - Baincrease of 25% to $13.3M (expense), Loss of earlyextinguishment of debt increase from $0K to $709K
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

MYO Revenue Unlock MYO Revenue

Net Income

MYO Net Income Unlock MYO Revenue

Normalised EPS

MYO Normalised EPS Unlock MYO Revenue

PE Ratio Range

MYO PE Ratio Range Unlock MYO Revenue

Dividend Yield Range

MYO Dividend Yield Range Unlock MYO Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
MYO EPS Forecasts Unlock MYO Revenue
Profile Summary

Myomo, Inc. is a United States-based medical device company specializing in myoelectric orthotics for people with neurological disorders. The Company’s products help to restore function in individuals with neuromuscular conditions, such as brachial plexus injury, spinal cord injury, multiple sclerosis and stroke. Its MyoPro myoelectric limb orthosis is a powered brace that supports a weakened and deformed arm for functional use. The MyoPro is an elbow/wrist/Hand orthosis, which supports the arm and helps to bend and straighten the arm at the elbow. The brace provides assistive function for joint motion that enables a user to self-initiate and control movements of a partially paralyzed arm using their own muscle signals. When the user tries to bend their arm, sensors in the brace detect the weak muscle signal, which activates the motor to amplify their weak muscle signal to help bend and move their arm. The brace uses non-invasive skin sensors.

Directors
Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated September 1, 2004
Public Since June 12, 2017
No. of Shareholders: 130
No. of Employees: 62
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange NYSE MKT
Shares in Issue 5,582,870
Free Float (0.0%)
Eligible for
ISAs
SIPPs
MYO Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for MYO
Upcoming Events for MYO
Frequently Asked Questions for Myomo Inc
What is the Myomo Inc share price?

As of 15/04/21, shares in Myomo Inc are trading at $10.38, giving the company a market capitalisation of £42.0m. This share price information is delayed by 15 minutes.

How has the Myomo Inc share price performed this year?

Shares in Myomo Inc are currently trading at $10.38 and the price has moved by 0.166k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Myomo Inc price has moved by 80.65% over the past year.

What are the analyst and broker recommendations for Myomo Inc?

Of the analysts with advisory recommendations for Myomo Inc, there are there are currently 1 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Myomo Inc is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Myomo Inc next release its financial results?

Myomo Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Myomo Inc dividend yield?

Myomo Inc does not currently pay a dividend.

Does Myomo Inc pay a dividend?

Myomo Inc does not currently pay a dividend.

When does Myomo Inc next pay dividends?

Myomo Inc does not currently pay a dividend.

How do I buy Myomo Inc shares?

To buy shares in Myomo Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Myomo Inc?

Shares in Myomo Inc are currently trading at $10.38, giving the company a market capitalisation of £42.0m.

Where are Myomo Inc shares listed? Where are Myomo Inc shares listed?

Here are the trading details for Myomo Inc:

Country of listing: United States
Exchange: ASQ
Ticker Symbol: MYO
What kind of share is Myomo Inc?

Based on an overall assessment of its quality, value and momentum, Myomo Inc is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Myomo Inc share price forecast 2021?

Shares in Myomo Inc are currently priced at $10.38. At that level they are trading at 73.41% discount to the analyst consensus target price of 0.00.

Analysts covering Myomo Inc currently have a consensus Earnings Per Share (EPS) forecast of -1.928 for the next financial year.

How can I tell whether the Myomo Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Myomo Inc. Over the past six months, the relative strength of its shares against the market has been 92.07%. At the current price of $10.38, shares in Myomo Inc are trading at 40.56% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Myomo Inc PE Ratio?

We were not able to find PE ratio data for Myomo Inc.

Who are the key directors of Myomo Inc?

Myomo Inc's management team is headed by:

Paul Gudonis - CEO
Steve Kelly - CHM
Jonathan Naft - GMG
Fredrick Nahm - OTH
David Henry - CFO
Who are the major shareholders of Myomo Inc?

Here are the top five shareholders of Myomo Inc based on the size of their shareholding:

AIGH Capital Management, LLC. Investment Advisor
Percentage owned: 7.77% (434k shares)
Triple Gate Capital, LP Hedge Fund
Percentage owned: 5.91% (330k shares)
Morgan Stanley Smith Barney LLC Investment Advisor
Percentage owned: 4.27% (238k shares)
Renaissance Technologies LLC Hedge Fund
Percentage owned: 2.33% (130k shares)
Worth Venture Partners, LLC Investment Advisor/Hedge Fund
Percentage owned: 1.97% (110k shares)
Similar to MYO
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.